BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 2009

View Archived Issues

Levodopa/carbidopa duodenal infusion improves psychiatric symptoms in Parkinson's disease patients

Read More

Roche discovers farnesoid X receptor agonists for the treatment of lipoprotein disorders

Read More

Botulinum toxin type A significantly improves major subtypes of cervical dystonia

Read More

Eculizumab appears to reduce the risk of acute humoral rejection in kidney transplant recipients

Read More

Roche presents Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis

Read More

Jimro claims novel CXCL10 production inhibitors

Read More

K-858 shows promising preclinical antitumor effects by specifically inducing tumor cell death

Read More

PolyMedix receives grant to support development of heptagonists

Read More

UPCI joins Gamida Cell's phase II ExCell study of StemEx in leukemia and lymphoma

Read More

Boehringer Ingelheim discovers ICAM-1 and LFA-1 interaction inhibitors for the treatment of asthma

Read More

Astellas discovers NMDA receptor antagonists for the treatment of Alzheimer's disease

Read More

ADX-10059 improves clinical GERD symptoms; data from a first-in-man study disclosed

Read More

Novel tryptophan hydrolase inhibitor LX-1031 under clinical development for irritable bowel syndrome

Read More

Synta and GSK to end collaborative agreement for elesclomol by September 2009

Read More

Boehringer and Vitae sign collaboration agreement to develop BACE inhibitors in AD

Read More

Thevac and undisclosed pharmaceutical company initiate testing of NanoViricides' eye drug

Read More

Axis-Shield and Hansa sign global agreement for exclusive rights to sepsis diagnostic assay

Read More

FDA accepts for filing and review OSI's sNDA for Tarceva in NSCLC

Read More

PTC receives two U.S. government grants to support development of PTC-299 and ataluren

Read More

Lilly initiates PD2 drug discovery initiative in Alzheimer's, cancer, diabetes and osteoporosis

Read More

Dr. Reddy's and GSK sign strategic alliance for emerging markets outside India

Read More

Adventrx sells shares to fund activities related to seeking FDA approval for vinorelbine

Read More

Celgene reports preliminary results from phase II study of apremilast in psoriatic arthritis

Read More

Alexza exercises option to purchase all of the equity of Symphony Allegro

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 10, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing